Hydroxychloroquine Effective for COVID Outpatients

The controversy over hydroxychloroquine will not go away.

The anti-malarial drug gained attention in March when President Trump said he was using it to prevent COVID-19. In May, the medical journal the Lancet published a study saying that the drug was potentially toxic, a study that was retracted in June because its data proved to be fraudulent. The Food and Drug Administration issued an emergency use authorization for the drug in late March and then revoked it in June when new evidence suggested it was ineffective. Then, in late July, a group calling itself America's Frontline Doctors generated controversy by releasing a video touting hydroxychloroquine as a treatment for COVID-19. The video was pulled by Facebook, YouTube, and Twitter.

 



Comment
Show comments Hide Comments


Related Articles